July 21, 2021 Acad, Gov/Utilities Other Lab Products/Services PAI Top-10

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes

Every year in the US, approximately 10,000 people are diagnosed with myelodysplastic syndromes (MDS), and there remains a high unmet need for new treatment options1 The designation is based on interim results from the phase Ib M15-531 study investigating Venclexta/Venclyxto plus azacitidine in people with previously untreated higher-risk MDS This is the 11th Breakthrough Therapy... Read more

July 19, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif., July 19, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune... Read more

July 5, 2021 Acad, Gov/Utilities Liq. Handling & Robotics

How Fruit Flies Become Male or Female

Researchers use structured illumination and confocal microscopy to study proteins involved in Drosophila sex determination The generation of offspring through sexual reproduction between a male and a female evolved approximately 1.2 billion years ago. An important part of this process is that each new generation contains both males and females in order to continue propagation... Read more

June 25, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy PR/Corporate

Roche’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children

The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more

June 24, 2021 Acad, Gov/Utilities Microscopy

FDA accepts application for Roche’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)

If approved, PDS would be the first and only eye implant with continuous drug delivery that offers people living with nAMD an alternative to frequent eye injections A pivotal study showed PDS extends time between treatments up to six months for more than 98% of patients and provides vision outcomes equivalent to monthly ranibizumab injections... Read more

June 21, 2021 Acad, Gov/Utilities Life Science Tools

Xylem Breakthrough Achieves up to 60% Energy Savings in Industrial Dewatering

New Dewatering Solution, Flygt Biboα, Uses Integrated Intelligence to Cut Repair and Maintenance Costs by up to 50% RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 21, 2021– Global water technology company, Xylem (NYSE:XYL), has today unveiled Flygt Biboα – a breakthrough dewatering pump that dramatically reduces energy, wear and tear, and maintenance costs. As the latest addition to... Read more

June 7, 2021 Acad, Gov/Utilities Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Collaborates with the University of Sheffield to Advance Oligonucleotide Characterization and Analytical Workflows

Thermo Fisher Scientific Collaborates with the University of Sheffield to Advance Oligonucleotide Characterization and Analytical Workflows HEMEL HEMPSTEAD, England, June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and the University of Sheffield, a leading institution with a global reputation for research excellence, have joined forces to develop advanced end-to-end... Read more